Peptide Therapeutics Market Overview, Business Opportunities future, growth 2027 - PowerPoint PPT Presentation

About This Presentation
Title:

Peptide Therapeutics Market Overview, Business Opportunities future, growth 2027

Description:

The peptide therapeutics market was valued at US$ 24,878.55 million in 2019 and is projected to reach US$ 50,003.15 million by 2027; it is expected to grow at a CAGR of 9.2% from 2020 to 2027. – PowerPoint PPT presentation

Number of Views:1

less

Transcript and Presenter's Notes

Title: Peptide Therapeutics Market Overview, Business Opportunities future, growth 2027


1
Peptide Therapeutics Market Analysis, Growth,
Share, Market Trends 2027
  • Published Date May 2022

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com
  • Peptide Therapeutics Market Forecast to 2027 -
    COVID-19 Impact and Global Analysis By Type
    (Generic and Innovative), Route of Administration
    (Parenteral, Oral, Mucosal, Pulmonary, and
    Others), Synthesis Technology (Solid Phase
    Peptide Synthesis (SPPS), Liquid Phase Peptide
    Synthesis (LPPS), and Hybrid Technology), and
    Application (Cancer, Cardiovascular Disorder,
    Metabolic Disorder, Respiratory Disorder, Pain,
    and Dermatology), and Geography

3
Peptide Therapeutics Market Overview
Email sales_at_theinsightpartners.com
  • The Peptide Therapeutics Market was valued at US
    24,878.55 million in 2019 and is projected to
    reach US 50,003.15 million by 2027 it is
    expected to grow at a CAGR of 9.2 from 2020 to
    2027.
  • The report highlights trends prevailing in the
    market, and the factors driving and hindering the
    market growth. The growth of the peptide
    therapeutics market is mainly attributed to the
    growing investments on peptide therapeutics and
    increasing prevalence of metabolic disorders and
    infectious diseases. However, operational
    limitations of peptides deter the market growth.

4
Key Segment Market
Email sales_at_theinsightpartners.com
  • Segment By Type-
  • By Type (Innovative, Generic and Others)
  • Application (Cancer, Metabolic Disorder,
    Cardiovascular Disorder, Respiratory Disorder,
    Pain, Dermatology)
  • By Technology (Solid Phase Peptide Synthesis
    (SPPS), Liquid Phase Peptide Synthesis (LPPS),
    Hybrid Technology)

Download Sample
5
Peptide Therapeutics Market Value
Email sales_at_theinsightpartners.com
  • CAGR of 9.2
  • (2020 - 2027)

Download Sample
6
Company Profiles
Email sales_at_theinsightpartners.com
  • Eli Lilly and Company
  • Amgen Inc.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD
  • Polypeptide Group
  • EVER Pharma GmbH
  • Bristol-Myers Squibb Company
  • Novo Nordisk A/S
  • Sanofi
  • AstraZeneca PLC
  • Glaxosmithkline PLC

Download Sample
7
By Geography
Email sales_at_theinsightpartners.com
  • North America (the US, Canada, and Mexico)
  • Europe (the UK, Germany, France, Italy, Spain,
    and the Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia,
    South Korea, and the Rest of Asia Pacific)
  • Middle East Africa (the UAE, Saudi Arabia,
    South Africa, and the Rest of Middle East
    Africa)
  • South Central America (Brazil, Argentina, and
    the Rest of South Central America).

8
THANKYOU!
  • Phone  1-646-491-9876
  • E-Mail sales_at_theinsightpartners.com
Write a Comment
User Comments (0)
About PowerShow.com